-
Taxonomy & unit
-
us-gaap: CAD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
ImmunoPrecise Antibodies Ltd. quarterly/annual General and Administrative Expense history and growth rate from Q4 2022 to Q4 2023.
- ImmunoPrecise Antibodies Ltd. General and Administrative Expense for the quarter ending January 31, 2024 was CA$4.18M, a 1.61% increase year-over-year.
- ImmunoPrecise Antibodies Ltd. annual General and Administrative Expense for 2022 was CA$19.8M, a 28.8% increase from 2021.
General and Administrative Expense, Quarterly (CAD)
General and Administrative Expense, YoY Quarterly Growth (%)